These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 32651266)

  • 1. A Differential Effect of Lovastatin versus Simvastatin in Neurodevelopmental Disorders.
    Muscas M; Seo SS; Louros SR; Osterweil EK
    eNeuro; 2020; 7(4):. PubMed ID: 32651266
    [No Abstract]   [Full Text] [Related]  

  • 2. Lovastatin, not Simvastatin, Corrects Core Phenotypes in the Fragile X Mouse Model.
    Muscas M; Louros SR; Osterweil EK
    eNeuro; 2019; 6(3):. PubMed ID: 31147392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Considerations for Clinical Therapeutic Development of Statins for Neurodevelopmental Disorders.
    Ottenhoff MJ; Krab LC; Elgersma Y
    eNeuro; 2020; 7(2):. PubMed ID: 32071072
    [No Abstract]   [Full Text] [Related]  

  • 4. The formation and secretion of cholesteryl esters in rat hepatocytes are reduced by lovastatin and simvastatin.
    Martínez MJ; Hernández ML; Isusi E; Aspichueta P; Ochoa B
    Biochem Soc Trans; 1998 Feb; 26(1):S82. PubMed ID: 10909840
    [No Abstract]   [Full Text] [Related]  

  • 5. Lovastatin corrects ERK pathway hyperactivation in fragile X syndrome: potential of platelet's signaling cascades as new outcome measures in clinical trials.
    Pellerin D; Çaku A; Fradet M; Bouvier P; Dubé J; Corbin F
    Biomarkers; 2016 Sep; 21(6):497-508. PubMed ID: 27058300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lowering of plasma cholesterol levels in animals by lovastatin and simvastatin.
    Chao Y; Chen JS; Hunt VM; Kuron GW; Karkas JD; Liou R; Alberts AW
    Eur J Clin Pharmacol; 1991; 40 Suppl 1():S11-4. PubMed ID: 2044637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparisons of effects of statins (atorvastatin, fluvastatin, lovastatin, pravastatin, and simvastatin) on fasting and postprandial lipoproteins in patients with coronary heart disease versus control subjects.
    Schaefer EJ; McNamara JR; Tayler T; Daly JA; Gleason JL; Seman LJ; Ferrari A; Rubenstein JJ
    Am J Cardiol; 2004 Jan; 93(1):31-9. PubMed ID: 14697462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of lovastatin on behavior in children and adults with fragile X syndrome: an open-label study.
    Çaku A; Pellerin D; Bouvier P; Riou E; Corbin F
    Am J Med Genet A; 2014 Nov; 164A(11):2834-42. PubMed ID: 25258112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug development for neurodevelopmental disorders: lessons learned from fragile X syndrome.
    Berry-Kravis EM; Lindemann L; Jønch AE; Apostol G; Bear MF; Carpenter RL; Crawley JN; Curie A; Des Portes V; Hossain F; Gasparini F; Gomez-Mancilla B; Hessl D; Loth E; Scharf SH; Wang PP; Von Raison F; Hagerman R; Spooren W; Jacquemont S
    Nat Rev Drug Discov; 2018 Apr; 17(4):280-299. PubMed ID: 29217836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual effect of lovastatin and simvastatin on LDL-macrophage interaction.
    Aviram M; Keidar S; Brook GJ
    Eur J Clin Chem Clin Biochem; 1991 Oct; 29(10):657-64. PubMed ID: 1764540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relative lipophilicities, solubilities, and structure-pharmacological considerations of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors pravastatin, lovastatin, mevastatin, and simvastatin.
    Serajuddin AT; Ranadive SA; Mahoney EM
    J Pharm Sci; 1991 Sep; 80(9):830-4. PubMed ID: 1800703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is a statin a statin?
    Wierzbicki AS
    Int J Clin Pract; 2001 Mar; 55(2):79-80. PubMed ID: 11321864
    [No Abstract]   [Full Text] [Related]  

  • 13. Action of lovastatin, simvastatin, and pravastatin on sterol synthesis and their antiproliferative effect in cultured myoblasts from human striated muscle.
    van Vliet AK; Nègre-Aminou P; van Thiel GC; Bolhuis PA; Cohen LH
    Biochem Pharmacol; 1996 Nov; 52(9):1387-92. PubMed ID: 8937448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tolerability of simvastatin.
    Br J Hosp Med; 1989 Sep; 42(3):239. PubMed ID: 2790367
    [No Abstract]   [Full Text] [Related]  

  • 15. [Simvastatin].
    Burgmer U; Mohr K
    Dtsch Med Wochenschr; 1996 Jun; 121(23):769-70. PubMed ID: 8646995
    [No Abstract]   [Full Text] [Related]  

  • 16. Simvastatin in the secondary prevention of coronary heart disease.
    Assmann G
    Pharmacol Res; 1997 Mar; 35(3):161. PubMed ID: 9229399
    [No Abstract]   [Full Text] [Related]  

  • 17. Lovastatin induces relaxation and inhibits L-type Ca(2+) current in the rat basilar artery.
    Bergdahl A; Persson E; Hellstrand P; Swärd K
    Pharmacol Toxicol; 2003 Sep; 93(3):128-34. PubMed ID: 12969437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholesterol-lowering drugs may boost bones.
    Vogel G
    Science; 1999 Dec; 286(5446):1825-6. PubMed ID: 10610568
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of atorvastatin, simvastatin, and lovastatin on the metabolism of cholesterol and triacylglycerides in HepG2 cells.
    Scharnagl H; Schinker R; Gierens H; Nauck M; Wieland H; März W
    Biochem Pharmacol; 2001 Dec; 62(11):1545-55. PubMed ID: 11728391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aldosterone secretion in patients treated with simvastatin and ACE inhibitors.
    Semplicini A; Valle R; Serena L; Rossi G; Pessina AC
    Am J Med; 1993 May; 94(5):559-560. PubMed ID: 8498408
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.